Individuals with first-episode schizophrenia experience varying degrees of cognitive impairment that can be categorized into 2 distinct subtypes.

Dementia among older adults in China correlates with a substantial increase in the need for functional support and routine safety monitoring.

There was relatively little difference between the leading causes of death between 2023 and 2024 in the US based on national statistics.

Pediatric patients receiving GLP-1 receptor agonist treatment appear to have higher rates of nutritional deficiency.

Early childhood growth and weight trajectories may be influenced by a mother's poor, late-pregnancy sleep quality.

Patients with atypical Alzheimer disease frequently fail to meet the clinical criteria required to receive targeted anti-amyloid therapies.

FDA approves Juvmo (tavapadon), a selective D1/D5 receptor partial agonist, for Parkinson disease based on phase 3 TEMPO trial data.

Patients with major depressive disorder may benefit from an intervention that reduces ultraprocessed food intake.

Fatigue and pain interference among cancer survivors with distress may be improved through mindfulness-based recovery and tai chi.

Few women initiate systemic hormone therapy for menopausal symptoms, and the majority of patients who do discontinue treatment within the first year.

Early life exposure to sugar appears to be associated with an increased risk for anxiety in adulthood and a lower preference for sweets.

Suicide rates are relatively stable throughout the 2017 to 2024 period, preceded by a climbing rate in the 2014 to 2017 period.